Tourmaline Bio Target Price vs. Number Of Employees
| TRML Stock | 26.04 0.38 1.48% |
For Tourmaline Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tourmaline Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tourmaline Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tourmaline Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tourmaline Bio over time as well as its relative position and ranking within its peers.
Tourmaline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.49) | Return On Assets (0.24) | Return On Equity (0.32) |
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tourmaline Bio Number Of Employees vs. Target Price Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tourmaline Bio's current stock value. Our valuation model uses many indicators to compare Tourmaline Bio value to that of its competitors to determine the firm's financial worth. Tourmaline Bio is currently regarded as top stock in target price category among its peers. It is rated second in number of employees category among its peers creating about 1.26 of Number Of Employees per Target Price. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tourmaline Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Tourmaline Number Of Employees vs. Target Price
Tourmaline Bio | = | 58.5 |
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Tourmaline Bio |
| = | 74 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Tourmaline Number Of Employees vs Competition
Tourmaline Bio is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 314. Tourmaline Bio totals roughly 74.0 in number of employees claiming about 24% of equities under Health Care industry.
Tourmaline Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tourmaline Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tourmaline Bio will eventually generate negative long term returns. The profitability progress is the general direction of Tourmaline Bio's change in net profit over the period of time. It can combine multiple indicators of Tourmaline Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 77 K | 80.9 K | |
| Operating Income | -45.4 M | -43.1 M | |
| Income Before Tax | -42.1 M | -40 M | |
| Total Other Income Expense Net | 3 M | 3.1 M | |
| Net Loss | -42.1 M | -44.2 M | |
| Income Tax Expense | -42.5 M | -44.6 M | |
| Net Loss | -42.1 M | -44.2 M | |
| Net Loss | (8.87) | (9.32) | |
| Income Quality | 0.67 | 0.80 |
Tourmaline Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tourmaline Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tourmaline Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tourmaline Bio's important profitability drivers and their relationship over time.
Use Tourmaline Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tourmaline Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will appreciate offsetting losses from the drop in the long position's value.Tourmaline Bio Pair Trading
Tourmaline Bio Pair Trading Analysis
The ability to find closely correlated positions to Tourmaline Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tourmaline Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tourmaline Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tourmaline Bio to buy it.
The correlation of Tourmaline Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tourmaline Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tourmaline Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tourmaline Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tourmaline Bio position
In addition to having Tourmaline Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
To fully project Tourmaline Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tourmaline Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tourmaline Bio's income statement, its balance sheet, and the statement of cash flows.